World Vision Working with the Global Fund Annual Report 2013 Fund Annual Report 2013 PDF.docx.pdfthe Global Fund Annual Report 2013 . ... ADVOCATE 1 World Vision Working with the Global

World Vision Working with

the Global Fund

Annual Report 2013

WV Working with the Global Fund 2013

1 EMPOWER, EQUIP, ADVOCATE

World Vision Working with the Global Fund 2013 Annual Report

1. Introduction

In 2013, World Vision expenditure for health programming from the Global Fund to Fight AIDS, TB and malaria

(the Global Fund) was $37 million.1 This financing institution is among the top three cash grant donors to

World Vision for all sectors and second only to the US government in grants for health. Three grants from

the Global Fund also were among the ten largest grants awarded to World Vision in 2013. Most important,

however, is the increasing number of people in World Vision communities who received life-saving prevention

and treatment for HIV and AIDS, TB and malaria due to our partnership with the Global Fund. These include

nearly 30,000 children who received care and treatment for AIDS in six countries, distribution of more than

3,300,000 insecticide-treated bed nets in three countries, and 34,000 patients enrolled in treatment in 10

countries for tuberculosis.

II. 2013 Global Fund Portfolio Overview

Current Portfolio - At the end of calendar year 2013, WV was implementing 28 grants for malaria, TB or HIV

and AIDS in 22 countries (five countries had multiple grants). These have a multi-year (1 - 3 years) value of

US$111,637,2902 and were leveraged by Support Offices for $4,018,907 in match, for a total current portfolio

value of $115,656 198. See the full list of current grants in Appendix 1.

World Vision Global Fund Portfolio Summary - December 31, 2013

# Awards Grant value

(USD)

Match value

(USD)

Total (USD)

Cumulative Grant Portfolio (total

of current +closed grants) 99 281,702,031 12,515,052 294,217,083

Current Grants (active phases) 28 111,637,290 4,018,907 115,656,198

Closed Grants 71 170,064,741 8,496,145 178,560,885

Pipeline (Additional Board

approved phases 2014-2016) 0 0 0 0

Acquisition

Total New Proposals 7

37,960,157

4,246,171

42,206,328

Newly signed awards (wins) 2

9,831,616

1,429,855

11,261,471

Pending (verbal approval, in negotiation) 1

1,000,000 1,000,000

Proposals (response pending) 1

155,000

27,000

182,000

Losses 3

26,973,541

2,789,316

29,762,857

1 GAM Report Q4 (year-end) FY13 January 2014, Global Field Operations Support Team, WVI

2 All $ values in this report refers to US dollars unless otherwise noted.



Acquisitions - During the calendar year there were seven new proposals (Burundi, Malawi, South Africa,

Sudan, Zimbabwe, Zambia and an extension in Papua New Guinea) totaling $37.9 million. Of these, two were

awarded (Zambia and PNG) for $9,831,616 with match from WV SOs of $1,429,855. The Sudan proposal was

verbally approved but is still in negotiation and the Malawi proposal is still pending a response from the donor.

The other three proposals were not approved.

Match - Cost share or match is not required in Global Fund grants, and not every grant has a Support Office to

provide match. Nevertheless, there has been a strong effort by the Global Centre to engage Support Offices to

assist with risk leveling and unallocated support costs. Support Office match was equal to 3.6 percent of the

current 2013 portfolio. In the current portfolio, the average match per grant by region was as follows: LAC

24%, East Asia 1.9%, East Africa 0.9%, Southern Africa 3%, MEER 10.8%, SAP 8.4% and WAR 16.9%.

Trends in Portfolio Growth

The cumulative portfolio value (chart 1) has

leveled out from 2011 and actually declined in 2013

for two main reasons. For three years, the new

awards and extensions have been smaller than the

value of grants ending, resulting in slowed growth.

Also, since 2011 our internal reporting has

improved and as every grant or phase closed we

began reporting the actual final grant value which is

usually less than the originally recorded award value

due to underspending during implementation. The

2013 level is a new, more accurate baseline.

The current portfolio (chart 2) includes multi-year

value of only active grants. The current grant portfolio

value declined steeply in 2011 as older major grants

closed and the Global Fund discontinued global Calls for

Proposals. The current portfolio stabilized somewhat

this year due to the signing of some large phase 2

renewals on top of acquisitions. All current grants with

Board approved five year amounts had signed phase 2

or extension by the end of the year so there are no

Board-approved future phases in the pipeline (chart 3).

Grant closures continued to outpace new grants in

2013 in number and total value (chart 3). From 2011-

2013, there has been very limited new funding for

grants from the Global Fund, which is the reason for

the decline in acquisitions, proposals and pipeline.

This situation is expected to improve in 2014 with the

$ M

$100 M

$200 M

$300 M

$400 M

2008 2009 2010 2011 2012 2013

1. Cumulative Portfolio 2008-2013

match

grant

-40%

-20%

0%

20%

40%

$ M

$50 M

$100 M

$150 M

$200 M

20

09

20

10

20

11

20

12

20

13

2. Current Portfolio 2009-2013

and growth rate

current

growth rate

0

50

100

150

200

250

300

$ M

illio

ns

3. Portfolio Trends-Annual Amount

cumulative

closed

current

pending&pipeline



launch of the New Funding Model and a new replenishment.

Portfolio by Disease and Region - East and Southern Africa continued to lead in total grant value, followed

by South Asia and Pacific and East Asia Regions. This regional distribution is quite similar to the regional

allocation of grant funding by the Global Fund.

The current WV portfolio is dominated by TB grants, which make up more than half, followed by malaria with

just over one third and HIV at only 10 percent. The Global Fund distribution by disease is: HIV 50%, malaria

33% and TB 17%. WV has not benefitted from the large amount of

HIV/AIDS funding awarded by the Global Fund, especially in Africa.

Although the WV portfolio contains eleven individual HIV grants,

these tend to be relatively small in value. This is partly because WV

has not recently been awarded a Principal Recipient grant for HIV,

there is a great deal of competition from national NGOs for HIV

programming, and also because in general more than half of the HIV

grant funding goes for pharmaceuticals, health supplies and clinical

services which is not an area of core competency for WV. Still,

given the importance of HIV and AIDS in the health strategy, WV

should more aggressively seek funding for HIV and AIDS from the

Global Fund, especially in Africa. In fact in 2013, WV did submit five

major proposals for HIV in East and Southern Africa, of which one

was awarded and one is pending.

Support Office Partnering - The WV SO-NO Partnering in Global Fund Grants policy which went into effect

in 2010 is now fully operational. All eligible applications for new and on-ongoing rounds in 2013 had an SO

partner identified either at the proposal or grant negotiation phase. There are still a few exceptions in countries

where either the grants are directed to national NGOs or for other reasons a co-signing foreign entity is not

allowed by the CCM or the Principal Recipient. In September 2013, GFU polled all SOs to update interest in

partnering on Global Fund grants and confirm eligibility (legal, technical and financial) and focus country interest.

Ten Support Offices in total registered interest.

Transition to the New Funding Model and Projected Revenue - For the last 3-year replenishment cycle,

which began in 2010, The Global Fund received a below-projection replenishment of US$9.2 billion, resulting in

0

10,000

20,000

30,000

40,000

50,000

East

Afr

ica

Sou

the

rnA

fric

a

West A

fric

a

East

Asia

Sou

th A

sia

& th

e P

acific

Latin

America/…

Mid

dle

East/East…

'000 U

SD

World Vision Global Fund Current

Portfolio by Disease and Region

December 2013

Malaria

TB

HIV

HIV 10%

TB 55%

Malaria 35%

World Vision Global Fund

Current Portfolio by Disease

December 2013



cancellation of global Calls for Proposals in 2011, 2012 and 2013. New grants for WV in those years came only

from local in-country calls based on earlier awards, usually as Sub-recipient, resulting in declining grant revenue.

In 2013, the Global Fund allocated a limited amount of reserved funding for a transition year to the New

Funding Model, inviting only six countries (called early applicants) to apply for $364 million in new grants. About

$1.5 billion was allocated to 47 countries (called interim applicants) for funding to extend or top-up existing

grants that were soon expiring. Five countries with WV presence were eligible in the New Funding Model pilot,

of which three countries (Myanmar, El Salvador and Zimbabwe) submitted national proposals in 2013. Of these,

WV participated only in Zimbabwe, but was not successful. WV Myanmar decided not to participate and

though WV El Salvador engaged in the country dialogue, in the end their preferred area of focus on youth was

not included as a key population in the national proposal. The Philippines and DRC postponed their national

proposals. Of the interim applicants, WV PNG was successful with its 18-month extension bid as Principal

Recipient (PR) and WV South Africa was not successful in its PR bid. Most interim applicant countries

requested small amounts of funding to top up or extend existing grants and did not call for new proposals from

NGOs. The new three year Global Fund replenishment held in December 2013 was more successful and this

funding will become available through the full roll out of the New Funding Model starting in April 2014. It is

hoped this will result in new grant opportunities for World Vision (See section VII).

III. Global Fund Portfolio Coverage and Performance

Global Fund grants continue to contribute to sustainable health results in WV communities. For the third year,

we are able to report the beneficiary coverage results from the current Global Fund grants. This year, we have

26 of 28 grants reporting, our best year yet. The indicators chosen are among the Global Fund top ten or

preferred indicators that are shared across at least two reporting offices. The annual results are for WV FY

2013. The cumulative results include the reported three year total for only those grants that still had activity in

FY2013. (Cumulative totals do not include amounts from grants that closed before 2013).

Working with the Global Fund Results FY 2013

Results for

2013

Cumulative

(2011-2013)

# grants

reporting

HIV and AIDS

Number of people received HIV test results 44,350 52,707 4

Number of people reached with BCC3 1,090,366 3,233,307 5

Number of adults receiving care and support 5,213 14,598 4

Number of children receiving care, including

OVC4 and ART5

13,796 29,416 6

Number of pregnant women received ARVs

to prevent mother to child transmission

376 377 2

People receiving anti-retroviral therapy 4,070 4,266 3

People trained in HIV service delivery 1,456 3,350 7

3 Behavior change communications 4 Orphans and Vulnerable Children 5 Anti-retroviral Therapy



Community groups formed for HIV care and

support

143 279 3

Tuberculosis

Number of new TB patients detected 27,158 54,292 7

Number of patients enrolled in DOTS6 21,710 34,751 10

People trained in improved TB service

delivery

10,834 42,783 10

TB service points supported 184 223 5

Malaria

Number of insecticide treated nets

distributed

1,818,503 3,361,345 3

Number of people trained in malaria service

including CHW7

10,119 20,589 4

Number malaria service delivery points

supported

81 353 3

Number of people with fever receiving

antimalarial treatment according to policy

128,885 130,243 2

IV. Partnership and Advocacy

Inter-Organization Task Team (IOTT) and Civil Society Principal Recipient Network (CSPRN) -

WV was invited to join the IOTT on Community Systems Strengthening (CSS) established by the Global Fund to

provide advice on the CSS investment case. Representing the CSPRN, WV facilitated the review and feedback

on the Investment Guide to Health and Community Systems Strengthening (HCSS) in January 2013. The HCSS

guide was made part of the Global Fund’s Transitional Funding Mechanism guidance package issued in early 2013

and later was made part of the Health System Strengthening (HSS) guidance package. In addition, WV has

facilitated the review and feedback on the CSS Investment Module and the CSS Informational Note in support of

the Global Fund’s New Funding Model.

WV also planned and facilitated a conference call on CSS and civil society engagement with the Global Fund as

part of CSPRN in January 2013. Mauro Guarinieri, from the civil society office of the Global Fund Secretariat,

was the guest speaker at this call. WV also led a core group project to revise the ToR of the CSPRN to focus

more on influencing the Global Fund strategy, reforms and the New Funding Model.

Resources and Advocacy Working Group of Ecumenical Advocacy Alliance (RAWG/EAA) – WV

and six other faith-based NGOs met with the new incoming Executive Director of the Global Fund, Amb. Mark

Dybul, to discuss a more consistent engagement of faith-based organizations (FBOs) in the New Funding Model

(NFM). As a follow up, RAWG/EAA contributed the names of FBOs in the Global Fund NFM countries that

should be invited to the country dialogue including WV national offices. In addition, RAWG/EAA was invited to

submit and WV contributed content about FBO organizational culture and capabilities for a training programme

for the Global Fund portfolio managers. This was in response to evidence that since the 2012 restructuring of

the Global Fund, many new staff do not understand the extensive role of FBOs in health service delivery or their

constraints to participation in Global Fund programs.

The EAA/RAWG also submitted to the Global Fund the report of its survey of FBO participation in Country

Coordinating Mechanisms (CCM) which found that 80 percent of CCM’s have at least one member from an

6 Directly observed treatment short-course 7 Community Health Workers



FBO and 70 percent of FBO members of CCMs are satisfied that they have an effective voice on the CCM. Yet

a majority of respondents (86 percent) expressed challenges such as lack of funding for FBOs, a need for skills in

monitoring and evaluation and Global Fund compliance, communications difficulties, weakness in grant

implementation, competency of faith leaders on technical health issues, a gap in collaboration between

government and civil society sectors, funding delays, and the expenses associated with attending CCM meetings.

Respondents expressed a strong interest in establishing network of FBOs engaged in the Global Fund to

strengthen learning, effectiveness and voice. EAA/RAWG is planning how to respond.

V. Global Fund Unit Strategic Support

Capacity Building and Knowledge Management - The Global Fund Unit (GFU) continued to be the

central hub for capacity building and knowledge management related to the Global Fund engagement, acquisition

and compliance, providing the following services:

Orientation conference calls and/or channeled information and resources to EASO, WARO, WVUK,

WV Australia, Ghana, Chad, Zimbabwe, and Uganda.

Direct technical support, advice and review for proposals from Sudan, Malawi, Burundi, Papua New

Guinea, Zimbabwe, and South Africa.

Quarterly webex conferences for information sharing with the ever growing Global Fund Interest

Group (GFIG). Topics focused on the GF’s New Funding Model, major board decisions and lessons

learned from implementing grants. WV Mozambique, Dominican Republic, Myanmar, PNG, Rwanda and

Thailand all contributed to webex calls during the year. The GFIG page on WVcentral was enhanced in

look and content and postings, announcements and emails were used to digest and highlight new

guidance and announcements. The GFIG’s Document Library was used as a model for other IGs.

The GFIG listserv rose from 190 to 336 (45% increase from 2012 and the largest Interest Group after

CHN) as a result of a Health Community of Practice (CoP) survey which assessed the level of interest in

the Interest Group (IG). The GFIG page experienced the highest page hits of all Health CoP IGs (the 7th

highest hits on WVCentral in general) and the member satisfaction survey yielded a score of 3.7 out of

5.0 (second highest of all CoP IGs).

Conducted a Global Fund and European Community Grant Acquisition and Management workshop at

the invitation of SAPO. The five day workshop was conducted in Jakarta for over 30 participants from

NOs in the region interested in acquiring or already implementing Global Fund grants.

Pre-positioning for the New Funding Model

During the first part of 2013, the GFU team focused on disseminating information and guidance about

the Global Fund New Funding Model and details of the transition year which began on 28 February. The

team worked closely with the five WV offices in the early applicant countries and many more in the

interim countries to advise on engagement, decision-making and ultimately with the proposals in three

countries.

In October 2013, the GFU team launched a global pre-positioning campaign to identify the national

offices that plan to prepare for proposals under the New Funding Model in 2014 and to pair them with

Support Offices based on mutual priorities and preferences. This new approach to SO-NO partnering,

permits the earlier involvement of Support Offices in the planning and preparatory stages, early



negotiation of partnering terms including match, early technical support from Support Offices, more

efficient technical support and capacity building from GC, and stronger partnerships. Twenty-three

National Offices and seven support offices have indicated their intent to work together to position for

funding in 2014-2015.

Coordination with GFO Grant Acquisition and Management (GAM) - With the establishment of

the WV GAM structure within GFO, GFU began to strategically coordinate with and leverage the new

structure in order to ensure smooth operational cooperation, gain greater visibility and support for the

Global Fund opportunities in World Vision, and to protect the current successful policies and business

process.

GFU coordinated with the GFO financial analyst to improve financial reporting of the Global Fund

portfolio.

GFU began to revise the WV Global Fund Business Process to incorporate the new GAM hubs as

stakeholders in Global Fund grant acquisition and management and to ensure alignment with emerging

GAM policies and procedures.

GFU began to leverage the GAM Community of Practice and GAM hub platform for strategic

communications, joint problem solving related to Global Fund acquisition and management activities.

Research and Resources from the Global Fund Unit - During the year, the team undertook two

research projects:

Health Financing Donor Landscape – GFU produced a paper, Development Assistance for Health –

Donor Landscape for Health Finance, describing global trends in donor assistance for health (DAH), in

order to identify areas of opportunity for WV.

Globally, DAH reached an historic high of

US$28.2 billion by 2010 and has remained flat

ever since. There have been significant

changes in the channels of funding. Since 2001,

steady growth in health funding of the govern-

ment donors and the appearance of the

vertical specialised channels for health (Global

Fund, Global Alliance for Vaccines and

Immunisations, etc.) were offset by significant

slowing of growth in funding for health from

the World Bank, regional development banks

and United Nations agencies. The US govern-

ment is now the largest individual donor for

health, followed by the Global Fund. The UN

specialized agencies (WHO, UNICEF, etc.),

while having large budgets for health, allocate only a small portion to NGOs. The World Bank funds

only 5 percent and regional development banks less than 2 percent of funding for global health, with

minimal amounts going to NGOs. All bilateral and multilateral donors are channeling funds to the

country level rather than through international NGOs as a strong trend.

Thailand Community Systems Strengthening Case Study - GFU collaborated with the World

Vision Development Foundation of Thailand to produce a case study of that country’s five –year project

called TB Reduction Among Non-Thai Migrants (TB-RAM), financed by the Global Fund. The paper

https://www.wvcentral.org/community/health/Documents/Development%20Assistance%20for%20Health%202013.pdf

https://www.wvcentral.org/community/health/Documents/Development%20Assistance%20for%20Health%202013.pdf

https://www.wvcentral.org/community/health/Documents/WVFT%20%20TB-RAM%20CSS%20Case%20Study-%20Final.pdf



highlights the community based approaches that contributed to objectives of increased case detection,

referral, treatment and cure. Project activities included community mobilization and systems

strengthening and were carried out by migrant health volunteers and other community volunteers using

community-based health posts as a point of interface with migrants. The project also included elements

of advocacy led by Thai staff who worked to strengthen linkages with the formal health system, local

immigration department, police department, community leaders and business owners to raise awareness

and support for migrant TB patients. The project had an 86 percent treatment success rate for all forms

of TB, which exceeded the target, and also exceeded the national treatment success rate of 79 percent.

VI. Update on the Global Fund

New Leadership - The Global Fund had completed 89 percent of the reforms listed in the

Consolidated Transformation Plan, former General Manager Gabriel Jaramillo said in an outgoing letter

on 18 January 2013 his last day at the Fund. The institution began the year with the appointment of a

new Executive Director, signaling the end of its year of transition and the full implementation of its new

structure, reforms, and vision. The new leader is Ambassador Mark Dybul, who had previously been the

Director of the United States Office of Global AIDS Coordinator (OGAC) which implements PEPFAR.

In his earliest statements, Dr. Dybul described a paradigm shift in the approach to international health

and development: one that views AIDS, TB and malaria as a series of micro –epidemics, requiring

contextualized, evidence-based analysis and response, particularly aimed at most affected communities.

Human rights began taking a front position in the financing institution, with a new focus for including

previously marginalized, highly impacted groups in national dialogue, grant-making, and investment

strategies.

The New Funding Model (NFM) - March 1, 2013 marked the beginning of a transition period for the

NFM with $1.9 billion allocated to 6 “early applicant” countries (defined as those that would apply for

new grants using all the steps of the NFM) and 48 “interim applicants” (countries defined as those that

would apply for extensions to existing grants using some of the steps of the NFM). Early and interim

applicants were selected based on whether disease programmes were currently receiving less than they

would under the NFM’s allocation principles based on disease burden and per-capita income level, or

were at risk of essential service interruptions from 2013 up to the end of September 2014, or were

positioned to achieve rapid impact. All other countries not on the lists of early and interim applicants

were encouraged to take steps to get ready for the full rollout of the NFM in 2014. These include

strengthening their national strategies, strengthening PR capacity and CCM capacity, and starting or

reinforcing the country dialogue process.

The NFM diverges dramatically from the previous acquisition procedures. There will no longer be

annual global Calls for Proposal and a competitive process resulting in winners and losers. The NFM is

designed to permit countries to apply for grants derived from their country health strategy, at a time of

their own choice throughout the year best suited to their specific national planning cycle. Proposals

(now called Concept Notes) are to be prepared as the result of an on-going inclusive country dialogue

and in an iterative consultation with the Global Fund Secretariat, resulting in proposals that are likely to

be approved by the Technical Review Panel (TRP) and the Grant Approval Committee (GAC).

Countries will also know their funding ceiling before preparing the Concept Note, meaning greater

predictability of aid flows. Detailed grant-making that finalizes all the documentation will precede the

Board approval so that disbursements and implementation can begin immediately thereafter, and the

whole process is now expected to take six months to one year, as opposed to the previous one to two

years. For more details on the NFM, as well as the new guidelines, tools and resources see here.

http://www.theglobalfund.org/en/fundingmodel/



In support of the transition and in preparation for the full roll out in April 2014, the Global Fund issued

a new template for the Concept Note, new guidelines to strengthen CCMs and provide for their annual

assessments, and new guidelines for minimum qualifications of Principal Recipients. The Board also

approved the amended policy on “Eligibility Criteria, Counterpart Financing Requirements and

Prioritization of Proposals for Funding from the Global Fund, which is to be used for resource allocation

needs of 2014-2016. The Board decision and the revised policy can be accessed here.

Replenishment - At the same time that the FFM was rolling out, the Global Fund was campaigning for

a financing replenishment to fund the next three years of grants. The year of fundraising, advocacy and

important early pledges culminated with a successful replenishment conference hosted in Washington,

DC and visibly supported by President Obama

and Secretary of State John Kerry who had

also pledged a 1:2 match from the US

government as an early encouragement to the

campaign. On 2-3 December 2013, world

leaders gathered to demonstrate

unprecedented global unity in the fight against

AIDS, TB and malaria pledging US$12.2 billion

in contributions from 25 countries, as well as

the European Commission, private

foundations, corporations and faith-based

organizations. That represented the largest

amount ever committed to the Fund. It was

a 30 percent increase over the US$9.2 billion

in firm pledges secured to finance the 2011-2013 period (excluding the US, a 55% increase). All the

traditional major donors signed pledge forms, (and thus no need for projections). They were joined by

the largest ever participation from the private sector which doubled its contribution to $680 million , as

well as pledges from African implementing governments including Cote D’Ivoire, Nigeria, Malawi, Kenya

and Zimbabwe who also announced increased domestic funding to fight the three diseases. A complete

list of pledges can be found here.

Results for the Global Fund - Going into 2013, the Global Fund had signed grants worth $13.2 billion

for HIV/AIDS, $6.75billion for malaria and $3.8 billion for TB. Programs supported by the Global Fund

in more than 140 countries have provided anti-retroviral treatment for AIDS to 6.1 million people, of

which 1.8 million were added in 2013. Programs have tested and treated 11.2 million people for TB, of

which 1.5 million were added in 2013, and have distributed 360 million insecticide-treated nets to

protect families against malaria of which 50 million were provided in 2013.

Ref: the Global Fund

The New Funding Model

Ref: The Global Fund

http://www.theglobalfund.org/documents/board/30/BM30_06-NFM-ECFP_Report_en/

http://theglobalfund.org/en/replenishment/fourth/



Annex 1

World Vision Global Fund Active Grant Portfolio 2013

Region National Office Engaged

SO Disease Focus

Amount of GF Grant *

Match Value-WV

Total Grant Value

Count of Grants

East Africa

Rwanda NA Malaria 397,001 0 397,001 1

Somalia Japan HIV 347,754 81,944 429,698 1

Somalia UK TB 36,700,000 0 36,700,000 1

South Sudan Japan Malaria 1,006,435 262,717 1,269,152 1

East Africa Total 38,451,190 344,661 38,795,851 4

East Asia

Cambodia New

Zealand HIV 531,906 94,708 626,614 1

Mongolia Australia TB 206,278 15,000 221,278 1

Myanmar UK Malaria 771,381 138,057 909,438 1

Myanmar UK TB 632,003 127,481 759,484 1

Thailand NA HIV 5,495,640 0 5,495,640 3

Thailand NA TB 6,148,292 0 6,148,292 2

East Asia Total 13,785,499 375,246 14,160,745 9

Latin

America/

Caribbean

Dominican Republic NA HIV 121,900 0 121,900 1

Haiti Germany HIV 337,537 169,527 507,064 1

Honduras Canada HIV 1,110,541 212,000 1,322,541 1

Latin America/Caribbean Total 1,569,978 381,527 1,951,505 3

Middle

East/Eastern

Europe

Bosnia &Herzegovina Switzer

land TB 1,084,228 110,840 1,195,068 1

Bosnia &Herzegovina Switzer

land HIV 647,406 75,455 722,861 1

Middle East/Eastern Europe Total 1,731,634 186,295 1,917,929 2

South Asia &

the Pacific

India NA TB 4,212,691 0 4,212,691 1

Papua New Guinea Australia TB 9,531,616 1,429,855 10,961,471 1

Philippines NA TB 3,200,000 0 3,200,000 1

South Asia & the Pacific Total 16,944,307 1,429,855 18,374,162 3

Southern

Africa

Congo - DR Japan HIV 785,000 117,750 902,750 1

Congo - DR Japan Malaria 1,855,021 278,253 2,133,274 1

Mozambique USA Malaria 34,950,000 712,577 35,662,577 1

Zambia NA HIV 300,000 0 300,000 1

Zimbabwe NA HIV 377,421 42,743 420,164 1

Southern Africa Total 38,267,442 1,151,323 39,418,765 5

West Africa

Senegal UK TB 460,289 100,000 560,289 1

Sierra Leone Canada Malaria 426,951 50,000 476,951 1

West Africa Total 887,240 150,000 1,037,240 2

Grand Total 111,637,290 4,018,907 115,656,198 28



Annex 2

For any questions regarding this report, please contact Ann Claxton: [email protected]